QUINLAN AMY enters VOYAGER THERAPEUTICS, INC. with 36.75K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/18/2026ACC: 0001104659-26-063176
Officer· Principal Accounting Officer
Since May 2026
36.75K
Baseline shares
100% direct
36.75K
Direct ownership
1 position
78.50K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned36.75K
Total
36.75K direct36.75K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 36.75K | Direct |
| Total | 36.75K | 36.75K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
28.50K
Shares owned
N/A
Exercise price
3.68
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
50K
Shares owned
N/A
Exercise price
5.28
Expiration
—
Exercise window
—
Total
Underlying
78.50K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 3.68 | — | — | 28.50K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 5.28 | — | — | 50K | N/A |
| Total | 78.50K | 0.00 | ||||